Bausch Health
BHC
#3923
Rank
NZ$5.90 B
Marketcap
NZ$15.78
Share price
3.07%
Change (1 day)
44.54%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): NZ-$3.88

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is NZ-$4.10. In 2025 the company made an earnings per share (EPS) of NZ$0.76 an increase over its 2024 EPS that were of NZ-$0.22.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$3.88-610.96%
2025NZ$0.76-450%
2024NZ-$0.22-92.59%
2023NZ-$2.93160.89%
2022NZ-$1.12-76.64%
2021NZ-$4.8168.45%
2020NZ-$2.85-68.91%
2019NZ-$9.18-57.11%
2018NZ-$21.39-272.22%
2017NZ$12.42-199.29%
2016NZ-$12.51798.7%
2015NZ-$1.39-128.31%
2014NZ$4.92-204.62%
2013NZ-$4.70602.7%
2012NZ-$0.67

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
NZ-$0.34-91.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
NZ-$1.72-58.15%๐Ÿ‡บ๐Ÿ‡ธ USA